New horizons in Biologics & Bioprocessing

NorthX Biologics invites you to join us on December 12th, for an inspiring event in Stockholm where our very own Magnus Gustafsson, Chief Commercial Officer, will be speaking on the topic of process development and GMP manufacture of biologics.

The development and GMP manufacture of biological drugs require precision and innovation to ensure safety, efficacy, and scalability. This presentation explores key strategies in the production of recombinant proteins, extracellular vesicles, viral vectors, and plasmid DNA – highlighting their roles in emerging therapeutics. We address challenges in process optimization, scalability, and regulatory compliance, emphasizing solutions to achieve robust and cost-effective production pipelines. Attendees will gain insights into the integration of advanced bioprocessing technologies and quality control measures that drive progress in biologics manufacturing. By aligning process development with GMP standards, we aim to support the successful translation of biologics from bench to bedside, meeting the demands of a rapidly evolving therapeutic landscape.

Be part of a forward-thinking community, ready to shape the next era of biologics and bioprocessing. Network, learn, and be inspired as we journey together towards a brighter, more innovative future.

Save the date!

Date: December 12th, 2024
Location: Stockholm, Sweden
Read more about the event here.

If you are interested in booking a meeting in advance, please fill out the form here.